Incyte
INCY
#1188
Rank
$20.16 B
Marketcap
$101.32
Share price
-0.40%
Change (1 day)
36.90%
Change (1 year)

Incyte (INCY) - Cash on Hand

Cash on Hand as of December 2025 : $3.58 Billion USD

According to Incyte's latest financial reports the company has $3.58 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Incyte - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31$3.58 B65.92%
2024-12-31$2.15 B-40.97%
2023-12-31$3.65 B12.88%
2022-12-31$3.23 B37.93%
2021-12-31$2.34 B30.36%
2020-12-31$1.80 B-14.93%
2019-12-31$2.11 B47.22%
2018-12-31$1.43 B22.97%
2017-12-31$1.16 B44.66%
2016-12-31$0.80 B14.24%
2015-12-31$0.70 B17.91%
2014-12-31$0.60 B17.93%
2013-12-31$0.50 B122.84%
2012-12-31$0.22 B-17.72%
2011-12-31$0.27 B-34.56%
2010-12-31$0.42 B-9.83%
2009-12-31$0.47 B137.56%
2008-12-31$0.19 B-22.78%
2007-12-31$0.25 B-19.51%
2006-12-31$0.31 B-7.65%
2005-12-31$0.34 B-26.57%
2004-12-31$0.46 B59.89%
2003-12-31$0.29 B-31.52%
2002-12-31$0.42 B-15.53%
2001-12-31$0.50 B-12.76%
2000-12-31$0.58 B770.22%
1999-12-31$66.9 M-39.84%
1998-12-31$0.11 B100%
1997-12-31$55.6 M631.58%
1996-12-31$7.6 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Novartis
NVS
$11.53 B 222.10%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$14.98 B 318.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$7.26 B 102.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$9.44 B 163.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$0.67 B-81.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
$0.38 B-89.37%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
$59.01 M-98.35%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
$77.39 M-97.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
$0.24 B-93.22%๐Ÿ‡บ๐Ÿ‡ธ USA